BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 31512855)

  • 21. Intercalating TOP2 Poisons Attenuate Topoisomerase Action at Higher Concentrations.
    Atwal M; Swan RL; Rowe C; Lee KC; Lee DC; Armstrong L; Cowell IG; Austin CA
    Mol Pharmacol; 2019 Oct; 96(4):475-484. PubMed ID: 31399497
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 5-Nitro-Thiophene-Thiosemicarbazone Derivatives Present Antitumor Activity Mediated by Apoptosis and DNA Intercalation.
    Roque Marques KM; do Desterro MR; de Arruda SM; de Araújo Neto LN; do Carmo Alves de Lima M; de Almeida SMV; da Silva ECD; de Aquino TM; da Silva-Júnior EF; de Araújo-Júnior JX; de M Silva M; de A Dantas MD; Santos JCC; Figueiredo IM; Bazin MA; Marchand P; da Silva TG; Mendonça Junior FJB
    Curr Top Med Chem; 2019; 19(13):1075-1091. PubMed ID: 31223089
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and structure of [(η(6)-p-cymene)Ru(2-anthracen-9-ylmethylene-N-ethylhydrazinecarbothioamide)Cl]Cl; biological evaluation, topoisomerase II inhibition and reaction with DNA and human serum albumin.
    Beckford F; Thessing J; Woods J; Didion J; Gerasimchuk N; Gonzalez-Sarrias A; Seeram NP
    Metallomics; 2011 May; 3(5):491-502. PubMed ID: 21347491
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Deubiquitinating Enzyme Inhibitor PR-619 is a Potent DNA Topoisomerase II Poison.
    Cowell IG; Ling EM; Swan RL; Brooks MLW; Austin CA
    Mol Pharmacol; 2019 Nov; 96(5):562-572. PubMed ID: 31515282
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel trifluoromethylated 9-amino-3,4-dihydroacridin-1(2H)-ones act as covalent poisons of human topoisomerase IIα.
    Infante Lara L; Sledge A; Laradji A; Okoro CO; Osheroff N
    Bioorg Med Chem Lett; 2017 Feb; 27(3):586-589. PubMed ID: 27998679
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cu(II) complexes with heterocyclic substituted thiosemicarbazones: the case of 5-formyluracil. Synthesis, characterization, x-ray structures, DNA interaction studies, and biological activity.
    Baldini M; Belicchi-Ferrari M; Bisceglie F; Pelosi G; Pinelli S; Tarasconi P
    Inorg Chem; 2003 Mar; 42(6):2049-55. PubMed ID: 12639140
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HU-331 is a catalytic inhibitor of topoisomerase IIα.
    Regal KM; Mercer SL; Deweese JE
    Chem Res Toxicol; 2014 Dec; 27(12):2044-51. PubMed ID: 25409338
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A novel indeno[1,2-b]pyridinone derivative, a DNA intercalative human topoisomerase IIα catalytic inhibitor, for caspase 3-independent anticancer activity.
    Jeon KH; Park C; Kadayat TM; Shrestha A; Lee ES; Kwon Y
    Chem Commun (Camb); 2017 Jun; 53(51):6864-6867. PubMed ID: 28604852
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis and biological evaluation of C1-O-substituted-3-(3-butylamino-2-hydroxy-propoxy)-xanthen-9-one as topoisomerase IIα catalytic inhibitors.
    Park S; Hong E; Kwak SY; Jun KY; Lee ES; Kwon Y; Na Y
    Eur J Med Chem; 2016 Nov; 123():211-225. PubMed ID: 27484510
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 64Cu-azabicyclo[3.2.2]nonane thiosemicarbazone complexes: radiopharmaceuticals for PET of topoisomerase II expression in tumors.
    Wei L; Easmon J; Nagi RK; Muegge BD; Meyer LA; Lewis JS
    J Nucl Med; 2006 Dec; 47(12):2034-41. PubMed ID: 17138747
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel 4-quinoline-thiosemicarbazone derivatives: Synthesis, antiproliferative activity, in vitro and in silico biomacromolecule interaction studies and topoisomerase inhibition.
    Ribeiro AG; Almeida SMV; de Oliveira JF; Souza TRCL; Santos KLD; Albuquerque APB; Nogueira MCBL; Carvalho Junior LB; Moura RO; da Silva AC; Pereira VRA; Castro MCAB; Lima MDCA
    Eur J Med Chem; 2019 Nov; 182():111592. PubMed ID: 31421632
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bimodal recognition of DNA geometry by human topoisomerase II alpha: preferential relaxation of positively supercoiled DNA requires elements in the C-terminal domain.
    McClendon AK; Gentry AC; Dickey JS; Brinch M; Bendsen S; Andersen AH; Osheroff N
    Biochemistry; 2008 Dec; 47(50):13169-78. PubMed ID: 19053267
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of the human topoisomerase IIbeta (TOP2B) promoter activity: essential roles of the nuclear factor-Y (NF-Y)- and specificity protein-1 (Sp1)-binding sites.
    Lok CN; Lang AJ; Mirski SE; Cole SP
    Biochem J; 2002 Dec; 368(Pt 3):741-51. PubMed ID: 12197834
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel nalidixic acid derivatives targeting topoisomerase II enzyme; Design, synthesis, anticancer activity and effect on cell cycle profile.
    Khalil OM; Gedawy EM; El-Malah AA; Adly ME
    Bioorg Chem; 2019 Mar; 83():262-276. PubMed ID: 30391699
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Coupling the core of the anticancer drug etoposide to an oligonucleotide induces topoisomerase II-mediated cleavage at specific DNA sequences.
    Infante Lara L; Fenner S; Ratcliffe S; Isidro-Llobet A; Hann M; Bax B; Osheroff N
    Nucleic Acids Res; 2018 Mar; 46(5):2218-2233. PubMed ID: 29447373
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Strong effect of copper(II) coordination on antiproliferative activity of thiosemicarbazone-piperazine and thiosemicarbazone-morpholine hybrids.
    Bacher F; Dömötör O; Chugunova A; Nagy NV; Filipović L; Radulović S; Enyedy ÉA; Arion VB
    Dalton Trans; 2015 May; 44(19):9071-90. PubMed ID: 25896351
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of Topoisomerases by Metal Thiosemicarbazone Complexes.
    Jiang X; Fielding LA; Davis H; Carroll W; Lisic EC; Deweese JE
    Int J Mol Sci; 2023 Jul; 24(15):. PubMed ID: 37569386
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis, Characterization, and in Vitro Anticancer Activity of Copper and Zinc Bis(Thiosemicarbazone) Complexes.
    Anjum R; Palanimuthu D; Kalinowski DS; Lewis W; Park KC; Kovacevic Z; Khan IU; Richardson DR
    Inorg Chem; 2019 Oct; 58(20):13709-13723. PubMed ID: 31339305
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Catalytic core of human topoisomerase IIα: insights into enzyme-DNA interactions and drug mechanism.
    Lindsey RH; Pendleton M; Ashley RE; Mercer SL; Deweese JE; Osheroff N
    Biochemistry; 2014 Oct; 53(41):6595-602. PubMed ID: 25280269
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The structure of DNA-bound human topoisomerase II alpha: conformational mechanisms for coordinating inter-subunit interactions with DNA cleavage.
    Wendorff TJ; Schmidt BH; Heslop P; Austin CA; Berger JM
    J Mol Biol; 2012 Dec; 424(3-4):109-24. PubMed ID: 22841979
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.